rs184263319

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003954.5(MAP3K14):​c.521G>A​(p.Cys174Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.000645 in 1,613,668 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00058 ( 8 hom. )

Consequence

MAP3K14
NM_003954.5 missense

Scores

1
10
3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.78

Publications

1 publications found
Variant links:
Genes affected
MAP3K14 (HGNC:6853): (mitogen-activated protein kinase kinase kinase 14) This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
MAP3K14 Gene-Disease associations (from GenCC):
  • NIK deficiency
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008482009).
BP6
Variant 17-45287170-C-T is Benign according to our data. Variant chr17-45287170-C-T is described in ClinVar as Benign. ClinVar VariationId is 544327.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.000582 (850/1461360) while in subpopulation AMR AF = 0.0181 (806/44652). AF 95% confidence interval is 0.017. There are 8 homozygotes in GnomAdExome4. There are 359 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP3K14NM_003954.5 linkc.521G>A p.Cys174Tyr missense_variant Exon 4 of 16 ENST00000344686.8 NP_003945.2
MAP3K14XM_047436997.1 linkc.521G>A p.Cys174Tyr missense_variant Exon 4 of 15 XP_047292953.1
MAP3K14XM_047436998.1 linkc.521G>A p.Cys174Tyr missense_variant Exon 5 of 16 XP_047292954.1
MAP3K14XM_011525441.3 linkc.521G>A p.Cys174Tyr missense_variant Exon 5 of 17 XP_011523743.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP3K14ENST00000344686.8 linkc.521G>A p.Cys174Tyr missense_variant Exon 4 of 16 1 NM_003954.5 ENSP00000478552.1
MAP3K14ENST00000376926.8 linkc.521G>A p.Cys174Tyr missense_variant Exon 3 of 15 1 ENSP00000482657.1
MAP3K14ENST00000617331.3 linkc.521G>A p.Cys174Tyr missense_variant Exon 5 of 17 5 ENSP00000480974.3

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
189
AN:
152190
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00275
AC:
682
AN:
248000
AF XY:
0.00201
show subpopulations
Gnomad AFR exome
AF:
0.000454
Gnomad AMR exome
AF:
0.0192
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000890
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.000582
AC:
850
AN:
1461360
Hom.:
8
Cov.:
32
AF XY:
0.000494
AC XY:
359
AN XY:
726946
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.0181
AC:
806
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111708
Other (OTH)
AF:
0.000530
AC:
32
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
52
104
157
209
261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00125
AC:
191
AN:
152308
Hom.:
2
Cov.:
32
AF XY:
0.00142
AC XY:
106
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41560
American (AMR)
AF:
0.0108
AC:
165
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000714
Hom.:
1
Bravo
AF:
0.00222
ESP6500AA
AF:
0.000753
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00213
AC:
257
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

NIK deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MAP3K14-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Benign
-0.015
T
BayesDel_noAF
Pathogenic
0.22
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D;D;D
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.77
.;T;.
MetaRNN
Benign
0.0085
T;T;T
MetaSVM
Uncertain
-0.15
T
PhyloP100
4.8
PrimateAI
Uncertain
0.70
T
REVEL
Uncertain
0.37
Sift4G
Uncertain
0.0020
.;D;D
Polyphen
0.99
D;D;D
Vest4
0.78
MVP
0.44
ClinPred
0.16
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.54
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184263319; hg19: chr17-43364536; API